Scpharmaceuticals Correlations

SCPH Stock

USD 4.94 0.08 1.65%

The current 90-days correlation between Scpharmaceuticals and DiaMedica Therapeutics is 0.05 (i.e., Significant diversification). The correlation of Scpharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Scpharmaceuticals Correlation With Market

Modest diversification

The correlation between Scpharmaceuticals and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Scpharmaceuticals Stock

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Scpharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.

Moving together with Scpharmaceuticals Stock

0.79	PFE	Pfizer Inc	Pair Corr
0.69	KMDA	Kamada	Pair Corr
0.85	CAT	Caterpillar	Pair Corr
0.76	AXP	American Express	Pair Corr
0.81	BA	Boeing	Pair Corr
0.88	CSCO	Cisco Systems	Pair Corr
0.82	JPM	JPMorgan Chase	Pair Corr
0.84	MSFT	Microsoft	Pair Corr
0.71	DD	Dupont De Nemours	Pair Corr
0.89	GE	GE Aerospace Earnings Call This Week	Pair Corr
0.85	IBM	International Business Earnings Call This Week	Pair Corr
0.72	MMM	3M Company	Pair Corr

Moving against Scpharmaceuticals Stock

0.53	MSB	Mesabi Trust	Pair Corr
0.36	VZ	Verizon Communications Earnings Call This Week	Pair Corr

Related Correlations Analysis

	CRNX	DMAC	FENC	IKT	MCRB	MIST	ONCY	PHAT	SRRK	VRCA
CRNX		0.49	-0.17	0.56	0.08	-0.13	-0.03	-0.19	0.2	-0.1	CRNX
DMAC	0.49		0.07	0.39	-0.06	-0.08	-0.29	-0.35	-0.03	-0.09	DMAC
FENC	-0.17	0.07		-0.48	0.31	0.83	0.42	0.72	0.56	0.76	FENC
IKT	0.56	0.39	-0.48		-0.05	-0.34	-0.24	-0.6	-0.25	-0.33	IKT
MCRB	0.08	-0.06	0.31	-0.05		0.27	0.86	0.37	0.77	0.62	MCRB
MIST	-0.13	-0.08	0.83	-0.34	0.27		0.43	0.73	0.53	0.6	MIST
ONCY	-0.03	-0.29	0.42	-0.24	0.86	0.43		0.56	0.84	0.75	ONCY
PHAT	-0.19	-0.35	0.72	-0.6	0.37	0.73	0.56		0.64	0.63	PHAT
SRRK	0.2	-0.03	0.56	-0.25	0.77	0.53	0.84	0.64		0.69	SRRK
VRCA	-0.1	-0.09	0.76	-0.33	0.62	0.6	0.75	0.63	0.69		VRCA
	CRNX	DMAC	FENC	IKT	MCRB	MIST	ONCY	PHAT	SRRK	VRCA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

ONCY	+ 0.86	MCRB
SRRK	+ 0.84	ONCY
MIST	+ 0.83	FENC
SRRK	+ 0.77	MCRB
VRCA	+ 0.76	FENC
VRCA	+ 0.75	ONCY

High negative correlations

PHAT	- 0.6	IKT
IKT	- 0.48	FENC
PHAT	- 0.35	DMAC
MIST	- 0.34	IKT
VRCA	- 0.33	IKT
ONCY	- 0.29	DMAC

Risk-Adjusted Indicators

There is a big difference between Scpharmaceuticals Stock performing well and Scpharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Scpharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CRNX	2.21	(0.10)	(0.01)	0.07	2.93	(2.39)	4.17	(5.78)	15.72
DMAC	3.21	0.22	0.05	0.37	3.56	(3.54)	7.23	(6.41)	23.31
FENC	2.57	0.55	0.24	0.48	2.14	(3.15)	6.71	(4.19)	17.35
IKT	3.87	(0.23)	(0.03)	0.00	4.20	(4.93)	10.20	(7.18)	27.87
MCRB	5.68	0.00	0.04	0.13	7.54	(6.48)	13.48	(8.59)	35.28
MIST	4.78	1.26	0.13	12.99	7.71	(5.49)	10.79	(7.79)	52.55
ONCY	5.33	1.37	0.28	4.81	4.08	(7.10)	16.46	(6.67)	39.80
PHAT	6.43	1.16	0.20	0.60	6.03	(8.41)	10.95	(10.96)	99.31
SRRK	3.22	0.41	0.14	0.41	3.01	(3.91)	7.18	(4.99)	22.87
VRCA	4.77	0.61	0.11	0.58	4.75	(6.23)	13.21	(9.09)	28.86

Scpharmaceuticals Corporate Management

John PharmD	Senior Affairs	Profile
Rachael Nokes	Principal Accounting Officer	Profile
Katherine Taudvin	Director Relations	Profile
Michael Hassman	Senior Operations	Profile
Steve Parsons	Senior Commercial	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC